Bone Repair Studies Started
Barcelona/Ann Arbor - US Aastrom Biosciences, Inc. and the Institut de Terapia Regenerativa Tissular (ITRT) announced in October that they will expand a bone graft study based on initial results from the first phase of patient treatments. The trial involved five patient treatments using Aastrom's Tissue Repair Cells (TRCs) for the bone graft repair of severe long bone non-union fractures, and was completed at the Hospital General de l'Hospitalet, Centro Medico Teknon and Hospital de Barcelona-SCIAS.
This trial was initiated in March 2004 in co-operation with ITRT who coordinated the trial implementation. The study was designed to evaluate the safety and effectiveness of TRCs to regenerate new, healthy bone in the repair of long bone non-union fractures. All of the patients who received TRC treatment had pre-viously failed to repair their fractures using standard procedures.